Dacarbazine Combined Targeted Therapy versus Dacarbazine Alone in Patients with Malignant Melanoma: A Meta-Analysis

BACKGROUND: Malignant melanoma is the most aggressive and deadly form of skin cancer. Dacarbazine (DTIC) has been the approved first-line treatment for metastatic melanoma in routine clinical practice. However, response rates with single-agent DTIC are low. The objective of this study was to compare...

Full description

Saved in:
Bibliographic Details
Published in:PLoS One
Main Authors: Jiang, Guan, Li, Rong-Hua, Sun, Chao, Liu, Yan-Qun, Zheng, Jun-Nian
Format: Artigo
Language:Inglês
Published: Public Library of Science 2014
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4263472/
https://ncbi.nlm.nih.gov/pubmed/25502446
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0111920
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items